Efficacy of doripenem in the treatment of Pseudomonas aeruginosa experimental pneumonia versus imipenem and meropenem-Reference-Cited by-同舟云学术

Efficacy of doripenem in the treatment of Pseudomonas aeruginosa experimental pneumonia versus imipenem and meropenem

Published:2010-09-21 Issue:11 Volume:65 Page:2423-2427
ISSN:1460-2091
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Bretonnière Cédric,Jacqueline Cédric,Caillon Jocelyne,Guitton Christophe,Le Mabecque Virginie,Miégeville Anne Françoise,Villers Daniel,Potel Gilles,Boutoille David

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/65/11/2423/13759450/dkq334.pdf

Reference21 articles.

1. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting;Navon-Venezia;Curr Opin Infect Dis,2005

2. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options;Obritsch;Pharmacotherapy,2005

3. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa;Rossolini;Clin Microbiol Infect,2005

4. Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones;Croisier;J Antimicrob Chemother,2002

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-08

2. Carbapenem Combinations for Infections Caused by Carbapenemase-Producing Pseudomonas aeruginosa: Experimental In Vitro and In Vivo Analysis;Antibiotics;2022-09-07

3. Anti-Mutant Efficacy of Combination Therapy with Doripenem and Levofloxacin: In Vitro Model Studies with Pseudomonas Aeruginosa;Antibiotics and Chemotherapy;2021-06-25

4. Comparative efficacy of doripenem versus meropenem for hospital-acquired and ventilator-associated pneumonia;Journal of Microbiology, Immunology and Infection;2019-10

5. Assessment of doripenem, meropenem, and imipenem against respiratory isolates of Pseudomonas aeroginosa in a tertiary care hospital of north India;Indian Journal of Critical Care Medicine;2017